// App-Quantinova.ai

: An electronic alert to reduce excessive prescribing of short-acting beta2-agonists for people with asthma in East London: a retrospective case-control study using routine primary care data

Researchers

Presenter

  • Shauna McKibben

Principal Investigators

  • Andy Bush

  • Mike Thomas

  • Chris Griffiths

Medical Centers

  • Asthma UK Centre for Applied Research, Queen Mary University London and Imperial College Healthcare NHS Trust, London, United Kingdom

  • Asthma UK Centre for Applied Research, Imperial College London, London, United Kingdom

  • Asthma UK Centre for Applied Research, University of Southampton, Southampton, United Kingdom

  • Asthma UK Centre for Applied Research, Queen Mary University of London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A